Once-weekly semaglutide versus placebo in patients with alcohol use disorder and comorbid obesity: a randomised, double-blind, placebo-controlled trial - The Lancet
·
0 reactions
·
0 comments
·
4 views
Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.
Original article
Google News
Anonymous · no account needed